| Dr Mark R Minor, MD | |
|
820 Bryan St, Suite 3, Huntingdon, PA 16652-2409 | |
| (814) 643-8474 | |
| (814) 643-8477 |
| Full Name | Dr Mark R Minor |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 820 Bryan St, Huntingdon, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720130107 | NPI | - | NPPES |
| 251881378 | Other | PA | UNITED HEALTH CARE |
| 0072073720003 | Medicaid | PA | |
| MI674735 | Other | PA | HIGHMARK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD044701L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Family Hospice And Palliative Care | Altoona, PA | Hospice |
| Penn Highlands Huntingdon | Huntingdon, PA | Hospital |
| Highlands Hospital | Connellsville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| J C Blair Memorial Hospital | 2668378407 | 40 |
News Archive
Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
In humans and animals, periodically recurring movements like walking or breathing are controlled by small neural circuits called "central pattern generators" (CPG). Scientists have been using this principle in the development of walking machines.
A University of Louisville scientist has found a way to prevent inflammation and bone loss surrounding the teeth by blocking a natural signaling pathway of the enzyme GSK3b, which plays an important role in directing the immune response.
› Verified 7 days ago
| Entity Name | Dubois Regional Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285728915 PECOS PAC ID: 8022917269 Enrollment ID: O20040119000522 |
News Archive
Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
In humans and animals, periodically recurring movements like walking or breathing are controlled by small neural circuits called "central pattern generators" (CPG). Scientists have been using this principle in the development of walking machines.
A University of Louisville scientist has found a way to prevent inflammation and bone loss surrounding the teeth by blocking a natural signaling pathway of the enzyme GSK3b, which plays an important role in directing the immune response.
› Verified 7 days ago
| Entity Name | J C Blair Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427269174 PECOS PAC ID: 2668378407 Enrollment ID: O20040121000045 |
News Archive
Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
In humans and animals, periodically recurring movements like walking or breathing are controlled by small neural circuits called "central pattern generators" (CPG). Scientists have been using this principle in the development of walking machines.
A University of Louisville scientist has found a way to prevent inflammation and bone loss surrounding the teeth by blocking a natural signaling pathway of the enzyme GSK3b, which plays an important role in directing the immune response.
› Verified 7 days ago
| Entity Name | Dubois Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245410554 PECOS PAC ID: 5890689715 Enrollment ID: O20040426000432 |
News Archive
Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
In humans and animals, periodically recurring movements like walking or breathing are controlled by small neural circuits called "central pattern generators" (CPG). Scientists have been using this principle in the development of walking machines.
A University of Louisville scientist has found a way to prevent inflammation and bone loss surrounding the teeth by blocking a natural signaling pathway of the enzyme GSK3b, which plays an important role in directing the immune response.
› Verified 7 days ago
| Entity Name | J C Blair Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1861575938 PECOS PAC ID: 7416051545 Enrollment ID: O20070329000662 |
News Archive
Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
In humans and animals, periodically recurring movements like walking or breathing are controlled by small neural circuits called "central pattern generators" (CPG). Scientists have been using this principle in the development of walking machines.
A University of Louisville scientist has found a way to prevent inflammation and bone loss surrounding the teeth by blocking a natural signaling pathway of the enzyme GSK3b, which plays an important role in directing the immune response.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark R Minor, MD 820 Bryan St, Suite 3, Huntingdon, PA 16652-2409 Ph: (814) 643-8474 | Dr Mark R Minor, MD 820 Bryan St, Suite 3, Huntingdon, PA 16652-2409 Ph: (814) 643-8474 |
News Archive
Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
In humans and animals, periodically recurring movements like walking or breathing are controlled by small neural circuits called "central pattern generators" (CPG). Scientists have been using this principle in the development of walking machines.
A University of Louisville scientist has found a way to prevent inflammation and bone loss surrounding the teeth by blocking a natural signaling pathway of the enzyme GSK3b, which plays an important role in directing the immune response.
› Verified 7 days ago
Dr. Jennifer Holt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 Warm Springs Avenue, Jc Blair Memorial Hospital, Huntingdon, PA 16652 Phone: 814-643-8850 Fax: 814-643-8334 | |
Daniel Delp, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 814 Washington St, Huntingdon, PA 16652 Phone: 814-643-4415 | |
Dr. James Fredrick Frommer Jr., D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 Warm Springs Ave, Huntingdon, PA 16652 Phone: 814-643-8556 Fax: 814-643-7014 | |
Michael A Lettieri, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 6674 Towne Center Blvd, Huntingdon, PA 16652 Phone: 814-643-1232 Fax: 814-643-4267 | |
Gregor Stanley Thebaud, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 835 Washington St, Huntingdon, PA 16652 Phone: 814-506-8114 Fax: 814-506-8553 | |
Dr. Niketu Patel, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1225 Warm Springs Ave, Huntingdon, PA 16652 Phone: 814-643-8408 | |
Dr. Dominick A Kistler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 Warm Springs Ave, Huntingdon, PA 16652 Phone: 814-643-2290 |